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Introduction
It is critically important that the cell has a tight control over 
the synthesis of the dCTP, dTTP, dGTP and dATP building 
blocks (dNTPs) needed for DNA replication and repair 
since the mutation rate increases dramatically if the lev-
els of the four dNTPs are either unbalanced or generally 
too high (Mathews, 2006). As illustrated in Figure 1, ribo-
nucleotide reductase (RNR) has a central role in the de 
novo synthesis of dNTPs by making deoxyribonucleotides 
from the corresponding ribonucleotides (Nordlund and 
Reichard, 2006). This enzyme is regulated on many lev-
els, including allosteric and transcriptional regulation, 
cell-cycle specific proteolysis in mammalian cells and by 
small inhibitory proteins such as Sml1 and Spd1 in yeasts 
(Nordlund and Reichard, 2006). We will only discuss the 
allosteric regulation in this review. Three different groups 
of enzymes in the deoxyribonucleotide synthesis pathway 
are subject to allosteric or feedback control (Figure 1): 
RNRs,  dCMP/dCTP  deaminases  (dCMPDA/dCTPDA) 
and deoxynucleoside kinases (dNKs). RNR is considered 
to be the master regulator, as verified by numerous stud-
ies of mammalian and yeast cell lines where its allosteric 
sites have been mutated. Many of these cell lines have 
severely skewed dNTP levels and dramatically increased 
mutation rates (Weinberg et al., 1981; Chabes et al., 2003; 
Kumar et al., 2011). Knowledge of RNR’s allosteric regula-
tion is also relevant for cancer therapy since many of the 
currently used anticancer drugs, including gemcitabine, 
cladribine,  fludarabine  and  clofarabine,  mimic  the 
natural substrates and allosteric effectors of this enzyme 
(Nocentini, 1996; Parker et al., 1991). The synthesis and 
regulation of the four dNTPs is a sophisticated task and, 
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despite RNR having attained a “scientific age” of over 50 
years, research on this enzyme continues to uncover new 
and fascinating aspects. In particular, two recent studies 
have contributed intriguing advances in our understand-
ing of the intricacies and complexities of its allosteric 
regulation (Fairman et al., 2011; Rofougaran et al., 2008).
three major RNR classes catalyzing 
equivalent radical chemistry
The  enzymatic  reaction  catalyzed  by  RNR  involves  a 
transient  cysteinyl  free  radical  in  the  active  site,  and 
RNRs have been organized into three main classes and 
a few subclasses (shown in Table 1) primarily based on 
how this radical is (re)generated in each catalysis cycle 
(Nordlund and Reichard, 2006). All classes of RNRs are 
believed to have evolved from a common ancestor since 
they share structural features in the active site. One of the 
most obvious similarities is a 10-stranded α/β-barrel, a 
unique tertiary structure that RNRs only share with glycyl 
radical enzymes, which are related functionally to class 
III RNRs. The mechanism of catalysis and free radical 
chemistry  of  the  RNR  classes  and  subclasses  are  well 
covered  by  previous  reviews  (Nordlund  and  Reichard, 
2006; Cotruvo and Stubbe, 2011a) and are therefore only 
briefly mentioned here. The RNR classes also differ in 
the nature of the substrate used: class I and some class 
II  RNRs  work  on  5′-nucleoside  diphosphates  (NDPs), 
whereas other Class II and class III enzymes operate at 
the 5′-nucleoside triphosphates (NTPs) level (Figure 1).
Class I RNRs (Nordlund and Reichard, 2006; Cotruvo 
and Stubbe, 2011a) are predominant in eukaryotes but 
are also found in several bacteria and viruses, as well as 
in a few archaea (Lundin et al., 2010). All class I RNRs 
contain two subunits, generally termed R1 (α) and R2 
(β), which are both essential for enzyme activity. The α 
subunit contains the catalytic site and in most cases two 
allosteric sites, whereas the β subunit in canonical class I 
enzymes harbors a tyrosyl radical that is able to generate 
the active site cysteinyl radical in the α subunit via a long 
range proton-coupled electron transport chain. Class I is 
sometimes referred to as the aerobic RNR since it needs 
oxygen to form a metal centre (an FeIII-O-FeIII centre in 
canonical class I RNRs) which is needed for the genera-
tion and stabilization of the tyrosyl radical in the β sub-
unit. Two subgroups of class I enzymes, termed class Ib 
and Ic (Cotruvo and Stubbe, 2011a), have a metal centre 
and radical chemistry that both deviate from the canoni-
cal class I enzymes (class Ia). The class Ib RNRs, which 
are only found in bacteria and bacteriophages, have a 
MnIII-O-MnIII/tyrosyl radical centre formed in the pres-
ence of the NrdI protein encoded in the class Ib operon. 
In the absence of NrdI class Ib can also form a canonical 
Fe-O-Fe/tyrosyl radical centre, but recent biochemical 
and genetic studies suggest that the Mn-variant is the 
physiologically relevant form (Martin and Imlay, 2011; 
Cotruvo and Stubbe, 2011b; Cox et al., 2010; Crona et al., 
2011b).  In  the  class  Ic  enzymes,  the  tyrosyl  radical  is 
replaced by another amino acid (Phe, Leu or Val) and the 
unpaired electron is provided by their MnIV-O-FeIII metal 
centre instead. In bacteria, archaea and bacteriophages, 
the α and β subunits are generally referred to as NrdA 
and NrdB (class Ia and Ic) or NrdE and NrdF (Ib).
Class  II  enzymes  are  found  in  bacteria,  archaea, 
viruses, and a few unicellular eukaryotes (Lundin et al., 
2010). These enzymes, often referred to as NrdJ, are not 
dependent  on  a  second  subunit  for  enzyme  activity 
and  instead  use  5′-deoxyadenosylcobalamin  (AdoCbl) 
Table 1.  RNRs are classified into three main classes (I-III) and a few subclasses differing in oxygen dependency, subunit composition, 
free radical chemistry, and allosteric regulation.
Classes Genes (subunits) Free radical chemistry Allosteric sites Active form: Inhibited form
Class I (Ia): aerobic NrdA (R1, α), 
NrdB (R2, β)
NrdB: Tyrosyl radical 
and Fe-O-Fe centre.
s-site + a-site 
(majority)
α2β2 (general) 
α6β2-6 (ATP, eukar.)
α4β4 (E. coli) 
α6β2 (eukar.)
Ib NrdE (R1E, α), 
NrdF (R2F, β)
NrdF: Tyrosyl  
radical and Mn-O-Mn 
(or Fe-O-Fe) centre.
s-site α2β2
† None
NrdI needed for the 
generation of the 
Mn-O-Mn centre.
Ic NrdA (R1, α), 
NrdB* (R2, β)
NrdB: Lacks tyrosyl 
radical. Unpaired e  
in Fe-O-Mn centre
α subunit associated features are equivalent to canonical class I 
(Ia) enzymes
Class II: oxygen 
independent
NrdJ (α) 5′-deoxyadenosyl  
radical generated  
from AdoCbl
s-site (rarely a-site) α (monomeric class II)  
α2 (dimeric class II)
?
Class III: anaerobic NrdD (α) NrdD: Glycyl radical. 
NrdG (activase)  
needed for the 
generation of the  
glycyl radical.
s-site + a-site 
(majority)
α2
† α2
†
*Named as NrdBPhe, NrdBLeu, NrdBVal depending on which amino acid the tyrosyl radical is replaced by.
†Additional complexes formed by the association of RNR subunits with activating components such as NrdI and NrdG are excluded from 
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for the generation of the cysteinyl radical. The class II 
RNRs can be subdivided into monomeric and dimeric 
enzymes with limited sequence homology. The dimeric 
class II enzymes are more closely related in their amino 
acid sequence to the class I enzymes than they are to the 
monomeric enzymes (Lundin et al., 2010).
Class III RNRs, NrdD, are found in bacteria, archaea, 
bacteriophages  and  a  few  eukaryotes  (Lundin  et  al., 
2010), They are only active under anaerobic conditions 
due to their oxygen-sensitive glycyl radical, which most 
likely  comes  into  direct  contact  with  the  active  site 
cysteine during the catalytic cycle (Logan et al., 1999). A 
second protein (NrdG) is needed for the initial genera-
tion of the glycyl radical but once formed, the radical is 
stable for several catalytic cycles. In eukaryotes the class 
III gene sequences NrdD and NrdG are fused into a single 
open reading frame (Lundin et al., 2010).
In  addition  to  the  main  subunits  and  free-radical 
activating  proteins  (NrdI  and  NrdG),  ribonucleotide 
reduction also involves factors that reduce the disulfides 
formed in the α protein during each catalytic cycle. Class 
I and II enzymes are reduced by thioredoxins and glu-
taredoxins, whereas the class III enzymes are reduced 
by formate. Even though thioredoxin has been observed 
to enhance the interaction of Escherichia coli R1 and R2 
(Kasrayan et al., 2004), complexes between RNR and glu-
taredoxin/thioredoxin have not been observed and the 
redoxins have no obvious effect on allosteric regulation. 
We will not discuss the reductants further in this review.
Each class of RNR has specific environmental require-
ments (e.g. oxygen, metal ion, and cofactor availabilities), 
and many bacteria and archaea encode more than one 
RNR operon within one and the same species (http://
rnrdb.molbio.su.se).  Microorganisms  that  live  both 
aerobically  and  anaerobically  could  for  example  have 
either a class II enzyme or a combination of class I and III 
enzymes. An advantage in the latter case is that they do 
not need AdoCbl for their dNTP synthesis. Interestingly, 
more than 5% of the fully sequenced bacterial genomes, 
one archeon, and three unicellular eukaryotes code for 
all three RNR classes, and it has been suggested that this 
may be beneficial for growth in rapidly fluctuating envi-
ronments (Lundin et al., 2010). For P. aeruginosa, which 
encodes all three classes of RNR, it has recently been 
shown that the three classes are differentially expressed 
(Torrents  et  al.,  2005;  Sjöberg  and  Torrents,  2011).  In 
eukaryotes, which almost exclusively have the canoni-
cal class I RNR, it is common that they have more than 
one canonical class I variant with different expression 
profiles. Mammalian cells use one variant of the small 
subunit  (R2)  for  DNA  replication  during  S-phase,  and 
another variant (p53R2) is expressed constitutively at a 
low level to supply the mitochondria with dNTPs. The 
p53R2 protein was originally identified as a DNA-damage 
inducible protein (Tanaka et al., 2000; Nakano et al., 2000) 
but later its low constitutive expression was suggested to 
be  important  for  mitochondrial  synthesis  (Håkansson 
et al., 2006). In a seminal study, p53R2 deficiencies were 
identified in several patients with mitochondrial deple-
tion syndrome (Bourdon et al., 2007).
General structure and allosteric sites of RNR
The allosteric regulation of RNR as we know it today was 
first discovered by Reichard and co-workers, who in 1969 
laid the basis for the generally accepted mechanisms of 
both specificity and activity regulation of the E. coli class 
Ia RNR (Brown and Reichard, 1969b). The specificity site 
(s-site) determines which substrates are reduced at the 
catalytic  site,  whereas  the  overall  activity  site  (a-site) 
acts  as  a  master  switch  that  can  turn  the  enzyme  on 
and off. As shown in Table 1, the specificity regulation 
RNR class I & II
UTP CTP ATPG TP
UDP CDP ADP GDP
dUTP dCTP dATP dGTP dTTP
dUDP dCDP dADP dGDP dTDP
UMP CMP AMP GMPd UMP dCMP dAMP dGMP dTMP
dUrd dCyd dAdo dGuo dThd
dCMPDA
dCTPDA
IMP UC A
I
G
De novo
purine
De novo
pyrimidine
dNKs
dNTP synthesis NTP synthesis
RNR class II & III
Figure 1.  NTP and dNTP synthesis with allosterically/feedback regulated enzymes in dNTP synthesis shown. The class of RNR used, the 
presence of different dNKs and the choice of dCMP or dCTP for deamination vary between species. Most eukaryotes (e.g. mammals) and 
gram positive bacteria use dCMP deaminase (dCMPDA) whereas most gram-negative bacteria use dCTP deaminase (dCTPDA). The one-
letter abbreviations in NTP salvage synthesis (U, C, A, G and I) stand for both the base and its corresponding ribonucleoside (I stands for 
hypoxanthine and inosine). Degradation pathways are generally not included with the exception of dephosphorylation events, which are 
shown by grey arrows unless they directly take part in dNTP synthesis. The dephosphorylations of (d)NTPs to (d)NMPs can both occur as 
a one-step procedure or via (d)NDPs. DNA building blocks: keeping control of manufacture  53
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is widespread across all classes, whereas the a-site pre-
dominates in class I (except Ib) and III RNRs. The class Ib 
enzymes are all truncated in the N-terminus, where the 
a-site is located, and have accordingly only s-site regu-
lation (Table 1). The class Ic enzymes will be treated as 
equivalent to canonical RNRs throughout the rest of the 
text since the Ic classification is entirely based on the β 
subunit (Högbom et al., 2004).
The active form of the catalytic subunit is generally 
a dimer with the s-sites located in the dimer interface 
(Figure 2), or is in higher-order complexes composed of 
several α dimers. The monomeric class II enzymes are 
an exception to this rule. In this case, the s-site is located 
within a structural element that mimics the dimer inter-
face found in the other classes (Sintchak et al., 2002). 
Accordingly, it can have a functional specificity regula-
tion although it is monomeric. In class I enzymes, which 
in contrast to class II and III enzymes contain both α 
and β subunits, the holoenzyme is generally described 
as an α2β2 complex. Higher oligomers of RNR were first 
observed as part of the groundbreaking early studies of 
allosteric regulation of the E. coli class Ia enzyme (Brown 
and  Reichard,  1969a).  In  analytical  ultracentrifugation 
experiments,  a  species  of  about  twice  the  molecular 
weight of the expected α2β2 heterotetramer was observed 
in the presence of dATP. Observations of oligomers were 
also made on class I RNRs from calf thymus and human 
tumor cells (Thelander et al., 1980; Cory and Fleischer, 
1982), but the concept of higher order oligomerization as 
a regulatory mechanism languished in obscurity until the 
2000s (Kashlan et al., 2002; Rofougaran et al., 2006; Wang 
et al., 2009; Rofougaran et al., 2008; Fairman et al., 2011). 
General for all these heavy complexes is that they have 
only been observed in class I enzymes with a functional 
a-site. We will return to this theme later in the review.
There are also some special variants of α2 and β2 struc-
tures among canonical class I and II RNRs. In the Aeh1 
bacteriophage class I RNR, each α protein is made up of 
two polypeptides αa and αb (Crona et al., 2011a). In this 
case, the active enzyme is an (αa + αb)2β2 complex. The 
class II RNR from P. aeruginosa is also split into two poly-
peptides, NrdJa and NrdJb, and a similar split is also pres-
ent in the genome of all γ-proteobacteria that encode a 
class II enzyme (Torrents et al., 2005). Saccharomyces cer-
evisiae has instead an extra variant of the R2 protein called 
R4, which is inactive by itself since it lacks important 
Figure 2.  Structures of catalytic subunits from different RNR classes with bound nucleotides highlighted. The a-sites, s-sites, catalytic sites 
and loop 2 are indicated by the labels a, s, c and 2, respectively. The ATP cones in each α subunit of the human class I enzyme are shown 
in orange or gold, respectively, whereas it is absent in the representatives from the other classes. Loop 1 and loop 2 are coloured in yellow 
and red, respectively.54  A. Hofer et al.
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ligating side-chains in its iron center, but is still needed to 
give the R2 subunit its correct folding (Wang et al., 1997; 
Chabes et al., 2000). In this case, the active form of the β2 
subunit is formally a ββ′ heterodimer composed of the 
R2 (β) and R4 (β′) proteins.
Nucleotide pools and general allosteric 
scheme
The allosteric regulation executed by the s-site prevents 
each dNTP from increasing too much in concentration in 
relation to the others. The physiological balance of dNTP 
concentrations  varies  from  organism  to  organism:  in 
mammalian cells (Traut, 1994) the dGTP pool is usually 
by far the lowest (5 μM) followed by dATP (24 μM), dCTP 
(29 μM) and dTTP (37 μM). In E. coli, the dNTP pools are 
generally 5–10 times higher but in this organism dGTP 
is also much lower in concentration relative to the other 
dNTPs (Buckstein et al., 2008). The dNTP concentrations 
are probably optimized to minimize the mutation rate 
depending  on  the  affinity  of  the  DNA  polymerase  for 
different nucleotides. It has been proposed for the bacte-
riophage T4 system that the dNTP balance is reflected in 
the GC content (Hendricks and Mathews, 1997), but this 
cannot be the explanation in mammalian and E. coli cells 
since the dGTP and dCTP concentrations do not follow 
each other in these species.
The allosteric s-site can bind ATP, dATP, dTTP, and 
dGTP. As exemplified for mammalian and E. coli class 
Ia RNRs in Figure 3, ATP and dATP stimulate the reduc-
tion of CDP and UDP, whereas dTTP and dGTP stimu-
late  GDP  and  ADP  reduction,  respectively  (Nordlund 
and Reichard, 2006). The validity of this regulation has 
been  demonstrated  in  several  ways  in  cultured  cells. 
One example that illustrates the s-site regulation is when 
cell  growth  is  temporarily  inhibited  by  hydroxyurea 
(Skoog and Nordenskjöld, 1971; Hofer et al., 1998), an 
antiproliferative drug known to inactivate class I RNRs. 
Directly after the removal of the drug, most dNTPs are 
very low due to the previous block in their synthesis. A 
notable exception is dTTP, which remains high since it 
can be obtained via salvage of thymidine from the culture 
medium (Bianchi et al., 1986). The first dNTP to increase 
is dGTP, followed by dATP and finally dCTP. The series 
of events can be explained by the scheme in Figure 3. At 
first, when only dTTP is present at high concentration, it 
will bind to the s-sites and stimulate dGTP production. 
The dGTP formed will subsequently stimulate dATP pro-
duction, which finally turns on the synthesis of dCTP/
dTTP. In this way, all four dNTP concentrations are soon 
in balance with each other and the normal homeostasis 
is re-established.
The s-site does not bind dCTP efficiently, and addi-
tional regulation of dCMP deaminase (dCTP deaminase 
in E. coli) is therefore required to regulate the dCTP/
dTTP ratio (Figure 3). The relative contribution of CDP/
CTP  or  UDP/UTP  as  the  ultimate  source  for  dTTP 
synthesis  varies  between  species,  with  Trypanosoma 
brucei  and  anaerobically  grown  bacteriophage  T4  as 
two extreme examples. T. brucei, which has very lim-
ited CDP/CTP supplies (Hofer et al., 1998; Hofer et al., 
2001), lacks dCMP/dCTP deaminase and makes all its 
dTTP from UDP reduction. The bacteriophage T4 class 
III enzyme is unable to reduce UTP (Andersson et al., 
2000) and uses hydroxymethyl-dCTP instead of dCTP. 
The dCTP formed in phage-infected cells is efficiently 
dephosphorylated to dCMP, which is further metabo-
lized  to  dTTP  (Figure  3)  and  hydroxymethyl-dCTP   
(Ji et al., 1991).
The  a-site  can  bind  either  ATP  (activator)  or  dATP 
(inhibitor) and is needed for turning the enzyme off when 
the cellular dNTP levels become too high (Nordlund and 
Reichard, 2006). ATP has similar affinities for both allos-
teric sites, whereas dATP has a 10-20 times lower affinity 
for the a-site than for the s-site in the mammalian and 
E. coli enzymes (Brown and Reichard, 1969b; Ormö and 
Sjöberg, 1990; Reichard et al., 2000). At sub-µM concen-
trations, dATP acts as a pure s-site regulator and at higher 
concentrations it binds to both allosteric sites and turns 
Figure 3.  Overview of the allosteric regulation of de novo dNTP 
synthesis. RNR is regulated by four different allosteric effectors 
(highlighted) and has both a specificity regulation that determines 
what substrate to reduce (arrows pointed towards RNR) and an 
overall  activity  regulation  that  can  turn  the  enzyme  off  when 
there is no need to synthesize more dNTPs (bottom box). Also 
included in the scheme is dCMP deaminase, which controls the 
concentration ratio between dCTP and dTTP (the organisms with 
dCTP deaminase have a similar regulation). Recently, it has been 
realized that Nature has chosen two different strategies to achieve 
the overall regulation (bottom box). The E. coli enzyme is turned 
off  by  high  dNTP/ATP  ratios  (dNTP = dATP,  dTTP  or  dGTP), 
whereas the mammalian enzyme can only be turned off by high 
dATP/ATP ratios. DNA building blocks: keeping control of manufacture  55
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the enzyme activity off. In contrast, ATP has low affin-
ity to both allosteric sites (KD ~100 μM in E. coli class I) 
but is still able to compete with the dNTPs for binding 
to the s-site and with dATP for binding to the a-site since 
it is present at ~3 mM in mammalian and E. coli cells 
(Bochner and Ames, 1982; Buckstein et al., 2008; Traut, 
1994). The overall activity regulation of the E. coli class 
Ia RNR was recently demonstrated to be mechanistically 
and functionally different from that of the mammalian 
enzyme  (Rofougaran  et  al.,  2008).  General  inhibition 
can both occur by dATP alone and by a cross-talk effect 
between the two allosteric sites where high dNTP levels 
in  combination  with  an  ATP-occupied  a-site  turn  the 
enzyme off.
During  the  history  of  research  on  RNR  allosteric 
regulation, some variations in the specificity regulation 
were  initially  observed  in  different  species,  including 
the E. coli, and T. brucei class Ia RNRs, but after more 
careful  scrutiny  they  can  be  rationalized  in  terms  of 
the scheme shown in Figure 3 (Rofougaran et al., 2008; 
Hofer et al., 1998). One reason for previous misconcep-
tions has been that the substrates have been tested one 
at a time and often only at a fixed concentration. When 
analyzing enzyme activity in one-substrate assays, it is 
easy to come to the wrong conclusion; for example dTTP 
is able to activate the reduction of all four substrates in 
E. coli when tested one at a time (Brown and Reichard, 
1969b) but preferentially reduces GDP in assays when all 
four substrates are present simultaneously (Rofougaran 
et al., 2008). A conclusion from these studies is therefore 
that  any  deviation  reported  in  the  specificity  regula-
tion should be verified in this type of assay before being 
accepted. Another problem with many in vitro studies is 
that they often disregard the fact that under physiologi-
cal conditions both the a-site (when present) and the 
s-site are occupied, and the effect of different dNTPs on 
enzyme specificity should therefore preferably be tested 
in the presence of ATP. Experiments on the T. brucei RNR 
illustrate the importance of having ATP in the a-site when 
testing the effect of allosteric effectors on RNR specificity: 
dGTP was the best inducer of CDP reduction of all effec-
tors when tested alone but the least efficient when tested 
in combination with ATP (Hofer et al., 1997). The T. bru-
cei RNR, was subsequently confirmed both in vitro and in 
vivo to follow the specificity regulation scheme shown in 
Figure 3 but has a deviating a-site regulation and cannot 
be generally inhibited by dATP (Hofer et al., 1998).
Specificity regulation – species similarities 
and differences in specificity and mechanism
The specificity regulation seems to be universal; it exists 
in all classes of RNRs and only a few members of the 
Herpesviridae class I enzymes lack it (Averett et al., 1983). 
It has been shown that herpes viruses have a low-fidelity 
polymerase, and this is one of the reasons why they are 
sensitive to many nucleoside analogs as antiviral agents 
(Hall et al., 1985). Possibly it could be an advantage for 
herpes viruses to have a high mutation rate in order to 
evolve more rapidly.
Many  RNRs  have  been  crystallized  in  the  presence 
of allosteric effectors and substrates and from all these 
studies it has been clear that there is a common theme 
in the mechanism of specificity regulation. The s-site is 
in contact with the catalytic site via a flexible loop (loop 
2). When the allosteric effector binds to the s-site, it alters 
the conformation of loop 2 in such a way that it makes 
the catalytic site more amenable to binding one substrate 
over the others. The s-site was first localized in the class 
Ia enzyme from E. coli through the structure determina-
tion of the R1 subunit in complex with dTTP and GDP 
(Eriksson et al., 1997). A set of three loops at the dimer 
interface (loops 1–3) was seen to respond to dTTP binding 
by changing conformation relative to the apo state. Loop 
2 appeared the most important of the three, as it formed a 
direct bridge between effector and substrate. Subsequent 
structural studies of the class Ib RNR from Salmonella 
typhimurium  established  that  the  various  dNTP  effec-
tors induced different conformational changes in loop 2 
(Uppsten et al., 2003). However, no substrate complexes 
were obtained for this system. In addition, the loop move-
ments in the active RNR are most likely dependent on 
the presence of the R2 protein, and both the E. coli and S. 
typhimurium structures were of R1 only.
A major breakthrough in understanding of specificity 
regulation was obtained through a study of seven com-
plexes of the dimeric class II RNR from Thermotoga mar-
itima (Larsson et al., 2004). Of these, four were effector/
substrate combinations (dTTP/GDP, dATP/CDP, dATP/
UDP and dGTP/ADP, and three were effector-only (dTTP, 
dATP and dGTP). This study provided a comprehensive 
picture of the detailed effects of dNTP-induced confor-
mational changes in loop 2 on substrate binding. Loop 2 
can be divided into an effector-proximal side and a sub-
strate-proximal side (Figure 4a). Effector binding induces 
different conformations of the effector-proximal side of 
loop 2 that project a variety of main-chain or side-chain 
atoms from loop 2 towards the substrate, always in a way 
that  matches  at  least  some  of  the  hydrogen-bonding 
pattern on the substrate base. This work also provided a 
demonstration that substrate and effector binding were 
to  varying  extents  cooperative,  in  line  with  biochemi-
cal  results  (von  Döbeln  and  Reichard,  1976;  Eriksson, 
1983;  Chimploy  and  Mathews,  2001;  Kasrayan  et  al., 
2004; Crona et al., 2010). dATP and dGTP by themselves 
structure loop 2 very similarly to the conformation in the 
substrate  complex.  However,  in  the  presence  of  dTTP 
alone loop 2 was largely unstructured (Figure 4b, grey 
structure). In this case, the addition of GDP was required 
to produce a fully ordered conformation (Figure 4a, grey 
structure). Interestingly, GDP is the only substrate whose 
base makes interactions with other elements of the active 
site than loop 2 in the T. maritima enzyme, thus it was 
proposed that GDP could be capable of binding in the 
presence of a loop 2 conformation that was not preformed 
(Larsson et al, 2004).56  A. Hofer et al.
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Given  the  high  similarity  in  the  loop  2  sequence 
between class I and II RNRs from a wide variety of spe-
cies, it was predicted that the conclusions from the T. 
maritima studies would be general for both classes. Two 
later studies on class I enzymes confirmed this predic-
tion. A similar series of complexes was determined for 
the class I RNR from S. cerevisiae (Xu et al., 2006) and, 
very recently, of the human RNR (Fairman et al., 2011). 
The existence of a large number of structures of class Ia, 
Ib and II enzymes from both prokaryotes and eukaryotes 
enables us now to assess the broader picture and look for 
similarities and differences between species:
Loop 2 clearly has a central role in all species, with  •	
conformational changes in loop 1 playing a comple-
mentary role. With few exceptions, effector base rec-
ognition uses main chain atoms only. The cooperative 
effect of GDP binding on the conformation of loop 2 
is also conserved across all species, with dTTP unable 
to structure the loop in isolation (Figure 4b). When 
dTTP and GDP are both present, loop 2 is structured, 
and only main-chain atoms and water molecules par-
ticipate in recognition of the substrate base (Figure 4c). 
Other similarities include the fact that the first residue 
of  the  effector-proximal  side  of  loop  2  is  projected 
towards the substrate in all dATP/CDP and dATP/UDP 
complexes (Figure 4d). While the exact details differ, it 
is evident that the fundamentals of the allosteric speci-
ficity regulation have been conserved across class I and 
II enzymes from evolutionarily very diverse species.
It should be borne in mind that the final conforma- •	
tions of loop 2 may to differing extents be dependent 
on the presence of the activating protein (R2 in class 
I) or cofactor (AdoCbl in class II). When the structure 
of the class II RNR was determined in the presence 
of dTTP, GDP and AdoCbl (Larsson et al., 2010), the 
conformation of loop 2 was seen to be subtly differ-
ent to that in the dTTP/GDP complex.
The essentiality of specificity regulation for RNRs is  •	
illustrated by the existence of the unusual group of 
monomeric class II enzymes in which the normally 
dimerization-dependent regulation is maintained by 
the insertion of a large structural block within the RNR 
β-barrel.  The  crystal  structure  of  the  Lactobacillus 
leichmannii RNR showed that the inserted piece con-
tains two α-helices that, together with two other heli-
ces, mimic the dimer interface required for specificity 
regulation, including loop 2 (Sintchak et al., 2002).
 Despite significant structural divergence, the class III 
RNRs provide an interesting study of the conservation of 
allosteric specificity regulation across large evolutionary 
Figure 4.  Structural basis for allosteric substrate specificity regulation. (a) The effect of different substrate-effector pairs on loop 2 structure 
in the T. maritima class II enzyme. Nucleotide carbon atoms and loop 2 are coloured grey for the dTTP/GDP complex, yellow for dGTP/
ADP, pink for dATP/CDP and light blue for dATP/UDP. The missing parts of loop 2 in the pink, blue and yellow structures were not visible 
in the crystal structures and represent unstructured elements. Note in particular the fully ordered loop 2 in dTTP/GDP and the projection 
towards the substrate of two different hydrogen-bonding residues, K202 and Q203, in dTTP/GDP and dATP/CDP(UDP), respectively. (b–c) 
Generality across species and RNR classes of the cooperative effect in the binding of dTTP and GDP. The complexes from T. maritima class 
II RNR are coloured grey, S. cerevisiae class Ia in pink, human in light blue and S. typhimurium class Ib in yellow (note that there is no 
dTTP/GDP complex available for S. typhimurium). In the absence of substrate, dTTP is unable to structure loop 2 (b) but in its presence (c), 
loop 2 becomes ordered and forms a cradle around the guanine base of GDP. Only main chain atoms and water molecules are involved in 
substrate base recognition. (d) Common features of specificity regulation also extend to the dATP/CDP and dATP/UDP complexes shown 
in light and dark grey, respectively, for T. maritima, and light and dark blue respectively for S. cerevisiae. Note that a glutamine residue 
(Q203 in T. maritima, Q288 in S. cerevisiae) from the effector-proximal side of loop 2 is always projected towards the substrate.DNA building blocks: keeping control of manufacture  57
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distances. To date, only one class III structure is known, 
that of the enzyme from bacteriophage T4, which has less 
than 20% sequence identity to the E. coli class I RNR. In the 
T4 enzyme the dimer axis is rotated by 90° relative to that in 
class I and dimeric class II, with the result that the effector 
binds in a pocket extending along the length of the helices 
at the dimer interface rather than being cradled by loops 
at the ends of the helix bundle (Logan et al., 1999; Larsson 
et al., 2001). This places the effector base 25 Å from that of 
the substrate, more than twice as far away as in class I and 
II. Effector identity is read out entirely by side chains rather 
than main chain atoms (Larsson et al., 2001). Nevertheless, 
a series of complexes with four different effectors clearly 
demonstrated conformational changes in loop 2 that prop-
agate to the part of loop 2 defined as “substrate proximal” 
in class I and II (Larsson et al., 2001). Thus the allosteric 
signal, despite being read out and transmitted in a differ-
ent way, terminates in the same place in all classes (Logan, 
2008). The class III RNR is potentially the most promising 
for structural studies of specificity regulation, since once it 
has been activated by its activase enzyme it can carry out 
several reaction cycles in the absence of a cofactor. Thus 
the conformation of the allosteric loops is most likely not 
affected by the activase. An additional approach that might 
contribute  to  a  deeper  understanding  of  the  specificity 
regulation is to compare the allosteric regulation of differ-
ent RNR classes from the same organism.
the AtP cone
With the revived interest in the formation of ATP/dATP-
induced  RNR  oligomers,  the  molecular  and  structural 
mechanisms of the overall activity regulation have just 
started to be revealed (Kashlan et al., 2002; Kashlan and 
Cooperman, 2003; Rofougaran et al., 2006; Rofougaran 
et al., 2008; Wang et al., 2009; Fairman et al., 2011; Aye and 
Stubbe, 2011). The a-site is an ATP cone domain in the 
N-terminus of the catalytic subunit (Aravind et al., 2000). 
The signature sequence of the ATP cone (VXKRDG) is 
present in nearly all canonical class I (including Ic) and 
III RNRs. In contrast, the ATP cone is very scarce in the 
class II enzymes and is not present at all in class Ib RNRs 
(Nordlund and Reichard, 2006). However, an ATP cone 
is not a guarantee for overall activity regulation since T. 
brucei and bacteriophage T4 class I enzymes, which both 
contain ATP cones capable of binding dATP, can never-
theless not be inhibited by dATP. Only a few examples of 
class II enzymes with ATP cones are known, and it is only 
the one from Pyrococcus furiosus that has been verified 
to have an overall activity regulation (Riera et al., 1997). 
There are also examples of RNR genes containing several 
ATP cones in tandem including the class I enzymes from 
Chlamydia trachomatis and P. aeruginosa (Roshick et al., 
2000; Torrents et al., 2006). Removal of the N-terminal 
ATP cone in the P. aeruginosa enzyme showed that this 
domain is required for a functional overall activity regu-
lation, whereas the truncated enzyme still could support 
a functional specificity regulation (Torrents et al., 2006).
The location and structure of the ATP cone domain and 
the basic binding mode of ATP to it have been known for 
several years (Eriksson et al., 1997), but it was only very 
recently that the first crystal structures of dATP and ATP 
bound to the ATP cone domain of the same RNR were 
published (Fairman et al., 2011), revealing the structural 
basis for discrimination between these two nucleotides. 
The ATP cone domain consists of four helices capped by 
a short β-hairpin (Figure 5). dATP was seen to bind more 
deeply in the pocket due to the absence of a 2′-OH group. 
Residue Ile18 (Ile22 in E. coli) was proposed to be essen-
tial for this discrimination by acting as a stereochemical 
barrier to the deeper binding of ATP. When residue Asp57 
is mutated to Asn (D57N), this eliminates the ability of 
the enzyme from mouse to discriminate between dATP 
and  ATP  (Weinberg  et  al.,  1981;  Eriksson  et  al.,  1981; 
Caras  and  Martin,  1988;  Reichard  et  al.,  2000).  Asp57 
makes  a  salt  bridge  between  two  Arg  residues  in  the 
a-site and possibly hydrogen-bonds to the 2′-OH group 
in the ATP complex. Mutation to Asn would presumably 
disrupt the electrostatic balance in the binding pocket, 
resulting in conformational changes that eliminate the 
ability to discriminate dATP from ATP. Interestingly the 
largest  conformational  differences  between  the  dATP 
and ATP complexes are found in the loop following the 
second helix of the domain (residues 45–52 in the human 
enzyme,  Figure  5),  which  is  an  important  part  of  the 
interface  connecting  α-dimers  in  the  dATP-inhibited 
Figure 5.  Structure of the ATP cone domain of human class I RNR 
in complex with dATP (blue) and ATP (red). Residue Asp57, which 
when mutated eliminates ability to discriminate between ATP and 
dATP, is shown in stick representation, as is one of its salt bridge 
partners,  Arg21.  The  helices  are  labeled  H1–H4.  The  residues 
involved in the interactions between three α dimers in the dATP-
inhibited  oligomer  (α6β2  complex)  as  determined  by  electron 
microscopy are shown as a gold surface. The largest differences 
between the two complexes are in the loop 45–52, which is an 
important component of the dimer-dimer interface.58  A. Hofer et al.
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α6β2 oligomer (Fairman et al., 2011). While it is not pos-
sible at present to correlate these differences directly to 
the two nucleotide binding modes, it seems very likely 
that modulation of the conformation of this area is key to 
the formation of different complexes in the presence of 
dATP and ATP (see below).
Significant differences are observed in the nucleotide 
binding  modes  when  comparing  the  human  enzyme 
with ATP to the E. coli R1 structure with bound AMPPNP 
(Eriksson et al., 1997). ATP binds further out of the pocket 
in the E. coli structure. This has been attributed to a differ-
ent conformation of the β-cap and an outwards displace-
ment relative to the rest of the ATP cone. The N-terminal 
portion of the first α-helix in the E. coli structure also 
protrudes further toward the ribose. Since the β-cap is an 
essential part of the dimer-dimer interface in eukaryotic 
α6 hexamers, one can speculate that subtle sequence-
dependent conformational differences in the response to 
ATP and dATP binding in just this region are responsible 
for the different oligomerization behaviors of eukaryotic 
and prokaryotic class I RNRs (see below).
Multiple mechanisms of overall activity 
regulation
Overall activity regulation of class I enzymes seems to 
be generally dependent on the formation of αn and αnβn 
oligomers. Allosteric effectors that only bind to the s-site 
stimulate the α subunit to dimerize and interact with the 
β2 subunit to form an active α2β2 complex (Figure 6). In 
the physiologically relevant situation where both allos-
teric sites are occupied, and in the presence of physiolog-
ical concentrations of α and β subunits, the mammalian 
RNRs form an α6β2 complex that is either active or inac-
tive depending on whether ATP or dATP is bound to the 
a-site (Rofougaran et al., 2006). Until recently, it has been 
an enigma how ATP and dATP can induce the same qua-
ternary structures but have opposing effects on enzyme 
activity.  A  low-resolution  x-ray  structure  of  the  dATP-
bound hexamer from S. cerevisiae begins to shed light on 
this problem by showing that it has a ring-like structure 
built up from three α dimers (Fairman et al., 2011). When 
a  point  mutation  (D16R)  in  the  observed  interaction 
interface between each dimer was introduced, the result-
ing protein was unable to form hexamers in the presence 
of dATP but could still form hexamers in the presence of 
ATP. This speaks strongly in favor of the dATP- and ATP-
induced complexes being structurally different. A cryo-
electron microscopy (cryo-EM) study of the inactive α6β2 
complex (formally a α6ββ′ complex) showed that the β2 
subunit was bound in the centre of the dATP-induced 
hexamer ring (Fairman et al., 2011) and it was suggested 
that it is locked in a position in which it cannot interact 
properly with the α subunit to form a functional electron 
transport chain. The positioning of β2 on the inside of 
the  ring  also  excludes  stoichiometries  for  the  inactive 
complex other than α6β2, since only one β dimer can be 
accommodated inside the ring.
In  contrast,  very  little  is  known  about  the  ATP-
induced α hexamer. Preliminary EM data show that a 
Figure 6.  Overall activity regulation in class I RNRs. General for this class is that all allosteric effectors are able to stimulate the formation 
of α dimers and active α2β2 complexes. In species with overall activity regulation, heavier complexes are formed in a species-dependent 
manner. In eukaryotes (mammals and S. cerevisiae), the α subunit can form a hexamer that interacts with the β2 subunit to form an inactive 
α6β2 or fully active α6β2-6 complex (higher activity than α2β2) depending on whether dATP or ATP is bound to the a-site. In E. coli, the α2β2 
complexes can bind to each other in the presence of dATP or effector combinations of ATP and high concentrations of dNTPs and thereby 
form an inactive α4β4 complex. The protein structures shown are α/α2 (human), α6 (S. cerevisiae), α6β2 (S. cerevisiae, based on cryo-EM 
structure) and a model of the α2β2 complex from E. coli built from separate structures of α2 and β2 (Uhlin and Eklund, 1994). DNA building blocks: keeping control of manufacture  59
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ring is also formed in the presence of ATP (Johansson 
& Logan, unpublished results) but the structural dif-
ferences  to  the  dATP-induced  hexamer  have  not  yet 
been  studied.  However,  gel  filtration  studies  of  the 
ATP-induced α hexamer show that it can bind up to 
three  β  dimers  if  the  substrate  analog  gemcitabine-
5′diphosphate  is  added  to  the  enzyme  (Wang  et  al., 
2009). Since it would not be possible to fit three β dimers 
in the centre of a hexamer ring of the type induced by 
dATP, the ATP-induced hexamer thus appears to have 
a quite different structure. The α6β6 form was predicted 
already in 2001 but was at that time not experimentally 
verified (Kashlan et al., 2002).
What is then the dominating RNR structure under in 
vivo conditions? Most in vivo studies have so far been 
performed on mammalian and yeast cells with the D57N 
mutation in the R1 a-site. The strongly increased dNTP 
pools in the mutated mammalian cell line (dGuo-200-1) 
as compared to the corresponding wild-type cell lines 
indicate that quite a large proportion of RNR is normally 
in its inhibited form (Weinberg et al., 1981). The D57N 
mutation caused increased dNTP pools also in yeast, but 
the difference was less pronounced than in mammalian 
cells  under  normal  growth  conditions  (Chabes  et  al., 
2003).  It  has  not  been  possible  to  study  directly  what 
quaternary structure the enzyme has inside the cells, but 
as mentioned previously, it has been clearly shown that 
dATP inhibition cannot occur when the surfaces keep-
ing the α hexamer together are mutated (Fairman et al., 
2011). It is therefore likely that the inhibited form is also 
an α6β2 complex in vivo. Similarly, it has not been possible 
to study directly what the main active RNR form is in vivo, 
but gel filtration and gas-phase-electrophoretic mobility 
macromolecule  analysis  (GEMMA)  experiments  show 
that at physiological concentrations of the RNR subunits 
and ATP, the α hexamer strongly predominates over the 
dimer, and that it mainly forms an α6β2 complex with the 
β subunit under these conditions.
Interestingly, the inhibition mechanism of the E. coli 
class  Ia  RNR  differs  from  that  of  the  mammalian  and 
yeast enzymes in several ways (Rofougaran et al., 2008). 
The E. coli enzyme has the ability to switch between an 
active α2β2 form induced in the presence of ATP, dGTP, 
dTTP or low concentrations of dATP and an inactive α4β4 
form induced by high concentrations of dATP or combi-
nations of dGTP/dTTP + ATP (Figure 6). In this RNR, the 
s- and a-sites communicate with each other to induce 
the formation of the inhibited complex. Cross-talk effects 
between the allosteric sites were observed already during 
the initial studies of the enzyme (Brown and Reichard, 
1969b), but the key role of the s-site in this regulation 
was not realized until recently. This was shown in experi-
ments  where  ATP  was  combined  with  dTTP  or  dGTP, 
two allosteric effectors that can only bind to the s-site 
(Rofougaran  et  al.,  2008).  When  ATP  is  used  alone,  it 
binds both allosteric sites and stimulates CDP and UDP 
reduction.  When  ATP  is  combined  with  intermediate 
dGTP or dTTP concentrations, the enzyme is still active 
but  switched  to  ADP  or  GDP  reduction,  respectively. 
However,  when  saturating  concentrations  of  dGTP  or 
dTTP are combined with ATP, the enzyme forms a gener-
ally inhibited α4β4 complex that cannot reduce any of the 
four substrates. In contrast, the mammalian enzyme has 
a different allosteric regulation where ATP is always an 
activator when it binds to the a-site regardless of which 
other nucleotide is present at the s-site. The difference 
between the species was demonstrated in experiments 
where increasing concentrations of ATP were added to 
a reaction in which dTTP-induced GDP reduction was 
studied  (Rofougaran  et  al.,  2008).  The  activity  of  the 
mammalian  RNR  was  increased  2.5-fold  whereas  the 
E. coli enzyme was nearly completely inhibited under 
similar conditions. The inhibition was also strong if other 
substrates were tested under these conditions.
As we have described previously, the ATP concentra-
tion is high enough in E. coli (~3 mM) to saturate the a- 
and s-sites at physiological conditions and, accordingly, 
a simplified scheme of αnβn complexes with fully occu-
pied allosteric sites can be made (Figure 7). It illustrates 
that the two allosteric sites can communicate with each 
other in such a way that the ATP-bound a-site is able 
to sense whether a dNTP or ATP is bound to the s-site. 
This dNTP can be either dTTP or dGTP and possibly also 
dATP. However, it is more difficult to verify the effect of 
dATP in the s-site since it will also compete with ATP for 
the a-site. The concentration dependence of dNTP + ATP 
inhibition was interpreted to mean that the formation of 
the α4β4 complex is a comparatively slow process in rela-
tion to the fast exchange of nucleotides at the allosteric 
sites. If communication between the sites is disturbed 
by ATP competing with dNTP for the s-site, the ability 
of the E. coli RNR to form the inhibited α4β4 complex is 
perturbed. Note that the equilibrium between the form 
with ATP in both sites (left panel in Figure 7) and the one 
with dNTP in the s-site and ATP in the a-site (middle top 
panel in Figure 7) needs to be very much pushed to the 
right for inhibition to take place, as evidenced by the 
experiment described above where increasing concen-
trations of dTTP/dGTP are added to the ATP-activated 
enzyme. A nearly complete shift in substrate specificity 
from CDP/UDP to the particular NDP specified by the 
dNTP in the s-site therefore occurs before the first signs 
of inhibition are observed (Rofougaran et al., 2008). A 
similar  inhibition  scheme  could  also  in  principle  be 
applied to dATP inhibition, but would be less straightfor-
ward to verify experimentally since dATP has the highest 
affinity of all nucleotides to the s-site. Interestingly, the 
s-site dNTP also had a strong effect on nucleotide affin-
ity for the a-site and in the presence of 2 mM dTTP, ATP 
inhibited the reaction with a similar IC50 value to dATP 
(Rofougaran et al. 2008). The communication between 
the two allosteric sites is quite remarkable given the long 
distance between them.
Another difference between the E. coli and mamma-
lian/yeast enzymes is the dependence on the β subunit 
for the formation of heavy complexes. The mammalian/60  A. Hofer et al.
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yeast α subunit can form α6 complexes in the presence of 
ATP or dATP, whereas the E. coli α subunit cannot form 
heavier complexes than α2 in the absence of the β sub-
unit. It is unlikely that the E. coli α4β4 octamer will have a 
structure in which the α subunits build a closed ring like 
in the eukaryotic α6β2 complex. In the α6β2 complex, all 
the ATP cone domains are in contact with each other, but 
attempts to model a closed ring from only two α2 dim-
ers lead to occlusion of the β2-binding surface (Logan, 
2011). Thus the E. coli α4β4 complex must have a differ-
ent structure. Perhaps this also explains why α tetram-
ers  have  never  been  observed  in  experiments  with  E. 
coli class Ia RNR (Rofougaran et al., 2008). The contact 
area between two ATP cone domains is simply too small 
to stabilize a tetramer in the absence of the β2 subunit. 
However,  the  relation  between  oligomerization  and 
allosteric regulation has so far only been studied in a few 
species and it is not known if the E. coli mechanism is 
widespread in bacteria. A recent comprehensive phylo-
genetic study suggests that the common ancestor of all 
eukaryotes inherited its class I RNR genes from bacteria 
other than alpha- (mitochondrial ancestor) or gamma-
proteobacteria (the group to which E. coli belongs) but 
it is not possible to identify exactly from which bacterial 
family (Lundin et al., 2010). Remarkably, there has also 
been a late transfer of the class I genes from a eukaryote 
to a group of the Bacteriodetes family (Lundin & al 2010). 
In order to better understand when the eukaryote variant 
of overall activity regulation first appeared in evolution, it 
would be interesting to study RNRs from a representative 
of this Bacteriodetes group as well as from deeply rooted 
eukaryotes.
A general question is how many different mechanisms 
of overall activity regulation there are, and whether there 
are any universal features common to all enzymes with 
this  regulation.  A  common  theme  in  the  E.  coli  and 
mammalian canonical class I RNRs is that the interaction 
between the α and β subunits in the heavy complexes 
is  tighter  than  in  the  corresponding  α2β2  complexes 
(Kasrayan et al., 2004; Crona et al., 2010; Ingemarson and 
Thelander, 1996; Birgander et al., 2004). A tighter inter-
action can both be favorable or unfavorable for enzyme 
activity depending on how the two subunits interact. A 
tight favorable α-β interaction could possibly explain the 
high enzyme activity of ATP-induced heavy complexes in 
eukaryotes.
Much less is known about the mechanisms of over-
all  activity  regulation  in  other  RNR  classes.  The  only 
representative  from  class  III  where  effector-induced 
protein  oligomerization  has  been  studied  is  the  one 
from  Lactococcus  lactis.  With  inhibiting  concentra-
tions of dATP, this enzyme seems to form only dimeric 
complexes both alone and in presence of the activase 
(Torrents et al., 2000; Torrents et al., 2001). Even less is 
Figure 7.  The s-site has a key role in overall activity regulation of the E. coli RNR. If the s-site is occupied by a dNTP, a cross-talk signal 
between the nucleotides in the two allosteric sites (double-sided arrow) leads to the formation of an inhibited α4β4 complex. At low dNTP 
concentrations, ATP is able to compete for the s-site and the enzyme rapidly equilibrates between the two top left forms in the figure. At 
higher dNTP concentrations, the concentration of the form shown in the top middle is high enough to promote formation of the inactive 
α4β4 complex (Rofougaran et al., 2008). The lower part of the picture shows that the inhibited form is also formed with dATP in the 
a-site. However, in this case it is not known whether the intermediate α2β2 form is active and if a cross-talk signal between the two sites 
is required for inhibition. Theoretically, a form with dATP in the a-site and ATP in the s-site is also conceivable, but is excluded from the 
scheme since it is uncertain if ATP ever can compete significantly with binding to the s-site when the dATP concentration is high enough 
to bind to both sites. DNA building blocks: keeping control of manufacture  61
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known about the class II enzymes. Only a few representa-
tives have an ATP cone sequence and the P. furiosus RNR 
is the only one biochemically characterized, which has 
been shown to be inhibited by dATP (Riera et al., 1997). It 
is not known whether dATP can induce heavy complexes 
in  this  species.  In  conclusion,  several  mechanisms  of 
overall activity inhibition exist in Nature, where at least 
two  different  oligomerization-dependent  mechanisms 
(canonical class I in eukaryotes and E. coli respectively) 
and one independent (class III in L. lactis) have been 
characterized. Despite the now available eukaryotic class 
I RNR α6β2 structure, the mechanistic details of the overall 
regulation are still intriguing. The regulation similarities 
within class I RNRs point to shared mechanistic features. 
However, the different inhibited oligomeric complexes 
also indicate individual solutions to the same task. In the 
inhibited α6β2 complex, the two subunits do not interact to 
produce a functional electron transport chain. It remains 
to be shown whether the same is the case for the E. coli 
α4β4 complex. The class II and III RNRs require   neither a 
second subunit nor a long range electron transport chain 
for enzyme activity, and can perhaps for that reason not 
be turned off by oligomerization. As the AdoCbl in class 
II and the glycyl radical in class III are very close to their 
active sites, a plausible mechanism could be to change 
the active site to directly disturb formation of the cystei-
nyl radical. Given the fundamentally different initiating 
radical donors in each RNR class and the sparse stud-
ies of class II and III overall activity inhibition, there are 
likely  important  “cofactor”-adapted  regulatory  details 
yet to discover.
All nucleotide binding sites in RNR 
communicate with each other
Although  the  only  structurally  defined  communica-
tion between nucleotide binding sites in RNR is the one 
between the catalytic site and the s-site, there is accu-
mulating evidence that all three nucleotide-binding sites 
communicate with each other. The long-range commu-
nication between the s- and a-sites described above is 
not unique to E. coli. In the mammalian enzyme, it has 
been shown that mutation of the a-site (D57N) also led 
to a seven-fold reduction in affinity of dATP for the s-site 
(Reichard et al., 2000). In other situations, it has been 
shown  that  the  a-site  needs  to  be  occupied  with  ATP 
in  order  to  achieve  a  correct  specificity  regulation  via 
the s-site (Hofer et al., 1997; Hofer et al., 1998). Further 
insight into the extensive cross-talk within RNR has been 
achieved from the studies of how different nucleoside 
analogs affect the enzyme. Many of the nucleoside ana-
logs used in cancer therapy are able to inhibit RNR by 
mimicking its substrates or allosteric effectors. Nucleoside 
analogs such as fludarabine, gemcitabine, cladribine and 
clofarabine are converted into their corresponding di- 
and triphosphates by nucleoside/nucleotide kinases and 
these can subsequently bind to the catalytic and allos-
teric sites of RNR (Nocentini, 1996; Parker et al., 1991). 
An unexpected recent finding was that α hexamers can 
be  induced  by  clofarabine-5′-diphosphate,  a  substrate 
analog that is unable to bind to the allosteric sites (Aye 
and Stubbe, 2011). One possibility could be that the sub-
strate analog is able to transmit a signal to the a-site that 
induces the protein to hexamerize.
concluding remarks
An ancestral RNR was a prerequisite for the transition 
from an RNA world to the DNA world more than 3.5 bil-
lion years ago. The unique structural core of contempo-
rary RNRs strongly implies that they all have a common 
origin, but the evolutionary time span has not allowed 
preservation of distinct amino acid sequence similari-
ties  among  the  contemporary  classes  of  RNR  (Lundin 
et  al.,  2010).  It  is  therefore  interesting  to  observe  that 
even though RNRs differ substantially in mechanisms to 
maintain dNTP homeostasis, they still manage to accom-
plish  a  common  output.  Even  though  comprehensive 
phylogenetic analyses show that it is not currently pos-
sible to identify which of the contemporary RNR classes 
that is most closely related to the ancestral RNR, we can 
still make a qualified attempt to order the appearance of 
the different levels of regulation and substrate phospho-
rylation levels during the evolution of the RNR family. 
The  ancestral  RNR  was  conceivably  a  ribonucleoside 
triphosphate reductase lacking allosteric regulation and 
working anaerobically, i.e. closer to a class II or III than 
to a class I RNR. Next to evolve was probably a common 
feedback control that gradually developed into an allos-
teric specificity regulation. The overall activity regulation 
is likely a character that developed later by adoption of 
the N-terminal ATP cone domain. It is hard to rational-
ize why some contemporary RNRs among bacteria and 
archaea seem to manage without this accessory sophis-
tication,  but  many  viruses  are  known  to  benefit  from 
less accurate DNA replication mechanisms. It cannot be 
excluded that the overall activity regulation has evolved 
more than once, but the strict N-terminal positioning of 
the ATP cone, when present, speaks for a single event, 
plausibly with several subsequent losses. What drew the 
switch  from  ribonucleoside  triphosphate  substrates  to 
ribonucleoside  diphosphate  substrates  is  not  obvious, 
and many contemporary organisms seem to cope well 
with  triphosphate  substrates.  The  fine-tuned  allosteric 
regulation that RNRs of modern organisms present have 
developed in several steps, in which allosteric regulation 
of  substrate  specificity  conceivably  preceded  develop-
ment of overall activity regulation, and where ribonu-
cleoside triphosphate substrates conceivably preceded 
ribonucleoside diphosphate substrates. With billions of 
years of evolution it is not surprising that several differ-
ent variants of RNR have evolved and that its allosteric 
regulation has reached the level of sophistication that we 
meet in contemporary RNRs.62  A. Hofer et al.
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